Swiss stocks - Factors to watch on May 3
ZURICH/BERLIN, May 3(Reuters) -Here are some of the main factors that may affect Swiss stocks on May 3:
Amgen Inc sued Novartis AG's Sandoz in New Jersey federal court Monday, accusing Sandoz's proposed versions of its multibillion-dollar bone-strengthening drugs Prolia and Xgeva of infringing several patents. (Full Story)
Sika has completed its acquisition of Germany-based MBCC after receiving all necessary regulatory approvals, the Swiss chemicals company said on Tuesday. (Full Story)
STRAUMANN HOLDING AG STMN.S
Q1 results due.
* OC Oerlikon OERL.S Q1 Group Sales Up At CHF 735 Mln - Reuters
BASILEA PHARMACEUTICA AG: BAADER HELVEA STARTS WITH BUY RATING; TARGET PRICE CHF 57.70
LOGITECH INTERNATIONAL SA: WEDBUSH RAISES TARGET PRICE TO $63 FROM $60
SIG GROUP AG: JEFFERIES RAISES TARGET PRICE TO CHF 28 FROM CHF 26
SKAN GROUP AG: CREDIT SUISSE RAISES TARGET PRICE TO CHF 95 FROM CHF 82
DORMAKABA HOLDING AG: CREDIT SUISSE CUTS TO NEUTRAL FROM OUTPERFORM; CUTS TARGET PRICE TO CHF 447 FROM CHF 590
LANDIS+GYR GROUP AG: TD COWEN RAISES TARGET PRICE TO CHF 87 FROM CHF 84
SWISS LIFE HOLDING SLHN.S - 30 CHF/shr dividend
BALOISE HOLDING AG BALN.S - 7.40 CHF/shr dividend
HELVETIA HOLDING HELN.S - 5.90 CHF/shr dividend
No major Swiss economic data scheduled.
Reporting by Zurich newsroom and Berlin Speed Desk
For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.